Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Porsolt Acquires Fluofarma | Contract Pharma

What are you searching for?

Sign in
Breaking News

Porsolt Acquires Fluofarma

Expands its in vitro drug discovery service capabilities

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Porsolt SAS, a preclinical in vivo efficacy and safety CRO, has acquired Fluofarm, expanding its capabilities and services that can assist clients at earlier stages of their drug discovery programs.

“The acquisition of Fluofarma complements Porsolt’s extensive drug discovery portfolio of services and capabilities addressing multiple stages of the drug discovery process,” said Guillaume Froget, president and chief executive officer, Porsolt. “This is an exciting development for Porsolt as we continue to grow to meet the needs of our well established global client base.”

Porsolt is a long established preclinical CRO with an international reputation for expertise in physio-pathological models, customized procedures, and tailored solutions for discovering treatments in multiple disease areas, including psychiatric and neurological disorders, acute and chronic pain, inflammation, cardiac and vascular diseases, metabolic and eating disorders, and dermatology, using disease models in multiple species. Porsolt also provides GLP safety evaluation of drug candidates from screening to regulatory studies before first-in-man administration, including full assessment of arrhythmogenic risk and abuse and dependence liability.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics